Table 1. Effect of XOS and β-Glucan on blood glucose of HFD-STZ-induced diabetic rats.
|
Blood Glucose |
Group |
P value |
|||
|
C |
D |
DX |
DBG |
||
|
Initial Glucose |
68.78 ± 1.65 |
68.78 ± 1.80 |
68.50 ± 1.82 |
69.91 ± 1.83 |
0.470 |
|
Pre-treatment glucose |
69. 82 ± 1.84 |
277.93 ± 5.94 |
282.54 ± 5.73 |
273.25 ± 9.77 |
0.000* |
|
Post treatment glucose |
71.48 ± 1.63 |
278.80 ± 5.63 |
101.87 ± 4.75 |
112.42 ± 6.74 |
0.000* |
|
Δ Glucose |
1.66 ± 0.72 |
0.87 ± 0.46 |
-180.67 ± 1.33 |
-160.84 ± 3.83 |
0.000* |
Initial glucose level was the level when selecting experimental animals for inclusion criteria; Pre-treatment glucose levels were glucose levels in rats after being induced by STZ and NA; Post-treatment glucose levels were glucose levels after being induced by STZ and NA and after being supplemented with XOS and β-glucan for 28 days; Delta Glucose is the difference between post-treatment glucose levels and pre-treatment glucose levels; C = control group; D = control negative (diabetic) HFD + STZ + NA; DX= Giving HFD + STZ + NA + XOS 450 mg/ 200 g BW; DBG = Giving HFD + STZ + NA + β-glucan 450 mg/200g BW; * = significant (p < 0.05).